AbbVie Inc. (ABBV)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 167.89 |
| Open | 168.59 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 168.29 - 170.37 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,623,520 |
| Market cap | 300.196B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 62.56 |
| EPS (TTM) | 2.71 |
| Earnings date | 26 Apr 2024 |
| Forward dividend & yield | 6.20 (3.66%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | 184.70 |
FortuneNvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
“We believe earnings growth is set for a healthier runway through 2024,” Morgan Stanley’s analysts wrote.
ZacksEli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
© 2024 Yahoo. All rights reserved.